Shewalton Road Riverside Business Park Irvine Ayrshire, Strathclyde
GlaxoSmithKline Wind Project (Turbine 4) is a 2.5 MW onshore wind project in Scotland. The applicant or operator on record is GlaxoSmithKline. It is recorded as operational since June 2014. The determining authority is North Ayrshire, reference 12/00629/PP.β¦
OperationalΒ· Since 2014
Project stageOperating
PlanningNov 2012 (completed)
ConsentedJun 2013 (completed)
ConstructionJan 2014 (completed)
OperatingJun 2014 (current stage)
Closed (not yet reached)
Status in the official register: Operational.
Official register: July 2026
Recorded status: Operational. Source record updated 2015-05-21.
Registered planning capacity; not measured generation.
GlaxoSmithKline Wind Project (Turbine 4) is a 2.5 MW onshore wind project in Scotland. The applicant or operator on record is GlaxoSmithKline. It is recorded as operational since June 2014. The determining authority is North Ayrshire, reference 12/00629/PP.
Site Schematic
Schematic diagram β not to scale. Illustrative layout based on project specifications.
π§ Technical Specifications
Capacity (MW)
2.500 MW
π Grid Connection & Infrastructure
π’ Development & Ownership
Developer
GlaxoSmithKline
Owner / operator
GlaxoSmithKline
Year consented
2013
Construction started
2014
Commissioned / target
2014
Location
Shewalton Road Riverside Business Park Irvine Ayrshire, Strathclyde